Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lubiprostone in pediatric functional constipation
NL-OMON41259Phase 3Active, not recruiting
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- Nov 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in functional constipation (FC) comparing Lubiprostone with Placebo (2 arms). Primary endpoint: Overall change from baseline in spontaneous bowel movement frequency across the 12-week treatment period. Started Nov 2014; status: active, not recruiting.
02
Drugs
cobiprostone
03
Conditions
functional constipation (FC)
Beyond the preview
Go deeper on NL-OMON41259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41259.